光智科技(300489.SZ):產品包含紅外機芯,無人機可搭載公司的紅外產品
格隆匯3月20日丨有投資者於投資者互動平台向光智科技(300489.SZ)提問,“大疆的專家反饋,紅外模組最近嚴重缺貨,請問大疆是否是公司的客户?公司業務是否包含紅外模組?這部分市場競爭力如何?”,公司回覆稱,公司具備從“材料生長、芯片設計、器件製備到系統集成”的全產業鏈規模化生產能力,可以為客户提供優質的光電產品和解決方案。公司的產品包含紅外機芯,無人機可搭載公司的紅外產品。基於商業保密原則,不便透露客户信息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.